Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Polymyositis
ADR ID BADD_A03504
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.05      Muscle disorders
15.05.01      Muscle infections and inflammations
15.05.01.004      Polymyositis
10      Immune system disorders
10.04      Autoimmune disorders
10.04.05      Muscular autoimmune disorders
10.04.05.004      Polymyositis
Description Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9) [MeSH]
MedDRA Code 10036102
MeSH ID D017285
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Polymyositis | Polymyositis hemorrhagica | Polymyositis haemorrhagica | Polymyositides | Myositis, Multiple | Multiple Myositis | Myositides, Multiple | Polymyositis, Idiopathic | Idiopathic Polymyositides | Idiopathic Polymyositis | Polymyositides, Idiopathic | Polymyositis Ossificans | Ossificans, Polymyositis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00178Atenolol0.000039%
BADD_D00467Cimetidine--
BADD_D00468Cimetidine hydrochloride--
BADD_D00537Cromoglycate--
BADD_D00653Diclofenac0.000026%
BADD_D00864Ezetimibe0.000251%
BADD_D00873Fenofibrate0.000039%
BADD_D01242Lamivudine0.001012%
BADD_D01257Letrozole0.000263%
BADD_D01318Lorazepam0.000031%
BADD_D01418Methotrexate0.000364%
BADD_D01709Penicillamine--
BADD_D01834Prednisone0.000009%
BADD_D01971Rosuvastatin0.000026%
BADD_D02026Simvastatin0.000051%
BADD_D02105Tacrolimus0.000594%
BADD_D02236Tofacitinib0.000362%
BADD_D02436Atorvastatin0.000009%
The 1th Page    1    Total 1 Pages
ADReCS-Target
ADR Term Drug Name Target